Analyst Price Targets — FTRE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 13, 2026 11:43 am | — | Mizuho Securities | $16.00 | $17.76 | TheFly | Fortrea price target raised to $16 from $13 at Mizuho |
| June 24, 2026 8:50 am | Luke Sergott | Barclays | $18.00 | $16.46 | TheFly | Fortrea price target raised to $18 from $16 at Barclays |
| May 7, 2026 12:41 pm | Justin Bowers | Deutsche Bank | $14.00 | $16.14 | TheFly | Fortrea price target raised to $14 from $11 at Deutsche Bank |
| May 6, 2026 1:29 pm | — | Truist Financial | $19.00 | $15.16 | TheFly | Fortrea price target raised to $19 from $16 at Truist |
| May 6, 2026 10:45 am | — | Robert W. Baird | $20.00 | $14.53 | TheFly | Fortrea price target raised to $20 from $15 at Baird |
| May 6, 2026 9:37 am | — | Barclays | $16.00 | $14.53 | TheFly | Fortrea price target raised to $16 from $11 at Barclays |
| April 14, 2026 10:42 am | — | Barclays | $11.00 | $9.38 | TheFly | Fortrea price target lowered to $11 from $12 at Barclays |
| January 14, 2026 2:36 pm | — | Robert W. Baird | $19.00 | $17.05 | TheFly | Fortrea price target raised to $19 from $15 at Baird |
| January 9, 2026 12:09 pm | — | Mizuho Securities | $15.00 | $17.44 | TheFly | Fortrea price target raised to $15 from $13 at Mizuho |
| January 8, 2026 10:13 am | Jailendra Singh | Truist Financial | $22.00 | $17.49 | TheFly | Fortrea upgraded to Buy from Hold at Truist |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for FTRE

DURHAM, N.C., July 13, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026.

Biotechnology stocks like Illumina, Eli Lilly and Exelixis have quietly turned into the new market leaders.

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Fortrea Holdings Inc. (FTRE) and argenex SE (ARGX). But which of these two stocks offers value investors a better bang for their buck right now?

DEC, FTRE, HG, PARR and KE have been added to the Zacks Rank #1 (Strong Buy) List on July 7, 2026.

Jason Knoblauch will succeed Jill McConnell as chief financial officer of Fortrea Jason Knoblauch will succeed Jill McConnell as chief financial officer of Fortrea
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for FTRE.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
